Consolidated Statements Of Shareholders' Equity - USD ($) $ in Thousands	Total	Auxilium Pharmaceuticals, Inc.	Par Pharmaceutical Holdings, Inc.	Total Endo International plc Shareholders’ Equity	Total Endo International plc Shareholders’ Equity Auxilium Pharmaceuticals, Inc.	Total Endo International plc Shareholders’ Equity Par Pharmaceutical Holdings, Inc.	Ordinary Shares	Ordinary Shares Auxilium Pharmaceuticals, Inc.	Ordinary Shares Par Pharmaceutical Holdings, Inc.	Euro Deferred Shares	Additional Paid-in Capital	Additional Paid-in Capital Auxilium Pharmaceuticals, Inc.	Additional Paid-in Capital Par Pharmaceutical Holdings, Inc.	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive (Loss) Income	Treasury Stock	Noncontrolling Interests
Shareholders' equity, beginning balance (in shares) at Dec. 31, 2013							144,413,074									(29,058,681)
Shareholders' equity, beginning balance at Dec. 31, 2013	$ 585,216			$ 526,018			$ 1,444				$ 1,166,375			$ 126,234	$ (4,915)	$ (763,120)	$ 59,198
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net (loss) income	(718,184)			(721,319)										(721,319)			3,135
Other comprehensive income (loss)	(122,471)			(119,173)											(119,173)		(3,298)
Compensation related to share-based awards	32,671			32,671							32,671
Forfeiture of restricted stock awards (in shares)							(3,298)
Exercise of options (in shares)							1,528,295
Exercise of options	41,392			41,392			$ 4				41,388
Tax benefits of share awards, net	$ 33,531			33,531							33,531
Issuance of ordinary shares related to the employee stock purchase plan (in shares)	75,450
Issuance of ordinary shares related to the employee stock purchase plan	$ 4,600
Ordinary shares issued (in shares)							36,235,228
Ordinary shares issued	2,844,366			2,844,366			$ 17				2,844,349
Euro deferred shares issued (in shares)										4,000,000
Euro deferred shares issued	55			55						$ 55
Tax withholding for restricted shares	(25,081)			(25,081)							(25,081)
Distributions to noncontrolling interests	(5,291)																(5,291)
Buy-out of noncontrolling interests, net	(1,729)																(1,729)
Addition of Paladin noncontrolling interests due to acquisition	38,800																38,800
Removal of HealthTronics, Inc. noncontrolling interests due to disposition	(57,359)																(57,359)
Result of contribution of Endo Health Solutions Inc. to Endo International plc (in shares)							(29,058,681)									29,058,681
Result of contribution of Endo Health Solutions Inc. to Endo International plc							$ (1,450)				(761,670)					$ 763,120
Conversion of convertible debt (in shares)							798,367
Repurchase of convertible senior subordinated notes due 2015	(309,829)			(309,829)							(309,829)
Settlement of common stock warrants	(284,454)			(284,454)							(284,454)
Settlement of the hedge on convertible senior subordinated notes due 2015	356,265			356,265							356,265
Other	315			315						$ (7)	322
Shareholders' equity, ending balance (in shares) at Dec. 31, 2014							153,912,985			4,000,000						0
Shareholders' equity, ending balance at Dec. 31, 2014	2,408,213			2,374,757			$ 15			$ 48	3,093,867			(595,085)	(124,088)	$ 0	33,456
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net (loss) income	(1,495,325)			(1,495,042)										(1,495,042)			(283)
Other comprehensive income (loss)	(256,708)			(256,213)											(256,213)		(495)
Compensation related to share-based awards	61,185			61,185							61,185
Exercise of options (in shares)							880,885
Exercise of options	27,217			27,217							27,217
Tax benefits of share awards, net	$ 20,051			20,051							20,051
Issuance of ordinary shares related to the employee stock purchase plan (in shares)	67,867						67,867
Issuance of ordinary shares related to the employee stock purchase plan	$ 4,299			4,299							4,299
Ordinary shares issued (in shares)							27,982,302
Ordinary shares issued	2,300,000			2,300,000			$ 3				2,299,997
Equity issuance fees	(66,956)			(66,956)							(66,956)
Ordinary shares issued in connection with acquisitions (in shares)								18,609,835	18,069,899
Ordinary shares issued in connection with acquisition		$ 1,519,320	$ 1,325,248		$ 1,519,320	$ 1,325,248		$ 2	$ 2			$ 1,519,318	$ 1,325,246
Tax withholding for restricted shares	(15,398)			(15,398)							(15,398)
Share repurchases (in shares)							(4,361,957)
Share repurchases	(251,088)			(251,088)										(251,088)
Buy-out of noncontrolling interests, net	(39,608)			(6,876)							(2,972)				(3,904)		(32,732)
Conversion of convertible debt (in shares)							5,170,239
Conversion of Auxilium Notes	160,892			160,892							160,892
Fair value of equity component of acquired Auxilium Notes	266,649			266,649							266,649
Settlement of common stock warrants (in shares)							1,792,379
Settlement of common stock warrants	0			0
Other (in shares)							(152)
Other	(15)			(15)						$ (5)	(10)
Shareholders' equity, ending balance (in shares) at Dec. 31, 2015							222,124,282			4,000,000						0
Shareholders' equity, ending balance at Dec. 31, 2015	5,967,976			5,968,030			$ 22			$ 43	8,693,385			(2,341,215)	(384,205)	$ 0	(54)
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net (loss) income	(3,347,050)			(3,347,066)										(3,347,066)			16
Other comprehensive income (loss)	30,809			30,771											30,771		38
Compensation related to share-based awards	59,769			59,769							59,769
Exercise of options (in shares)							62,589
Exercise of options	1,952			1,952							1,952
Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net	$ (5,449)			(5,449)							(5,449)
Issuance of ordinary shares related to the employee stock purchase plan (in shares)	306,918						306,918
Issuance of ordinary shares related to the employee stock purchase plan	$ 5,119			5,119							5,119
Ordinary shares issued (in shares)							460,386
Tax withholding for restricted shares	(11,500)			(11,500)							(11,500)
Other	(37)			(37)						$ (1)	(36)
Shareholders' equity, ending balance (in shares) at Dec. 31, 2016							222,954,175			4,000,000						0
Shareholders' equity, ending balance at Dec. 31, 2016	$ 2,701,589			$ 2,701,589			$ 22			$ 42	$ 8,743,240			$ (5,688,281)	$ (353,434)	$ 0	$ 0